Medicinal plants: a public resource for metabolomics and hypothesis development

Area of Science:

• Plant biology
• Metabolomics
• Drug discovery

Background:

• Medicinal plants are vital sources of natural products for drug development.
• Technological advancements enable deeper analysis of plant metabolomes.
• Understanding plant metabolism is key to unlocking new therapeutic compounds.

Purpose of the Study:

• To create a database and platform for storing, visualizing, and analyzing metabolomics and transcriptomics data from medicinal plants.
• To provide a framework for generating testable hypotheses on plant biochemistry, phylogeny, and natural product diversity.
• To facilitate the identification of genes involved in the biosynthesis of specialized compounds.

Main Methods:

• Collected and analyzed metabolomics and RNAseq data from fourteen medicinal plant species.
• Integrated metabolomics and transcriptomics data for comprehensive analysis.
• Developed a database and platform (Medicinal Plant Metabolomics Resource - MPM) for data management and statistical analysis.

Main Results:

• Demonstrated the utility of the MPM platform through case studies on Camptotheca acuminata, Prunella vulgaris, and Digitalis purpurea.
• Showcased how deep metabolomics can inform understanding of natural product chemical diversity and biogenesis.
• Illustrated the integration of metabolomics and transcriptomics for identifying biosynthetic pathway genes.

Conclusions:

• The MPM provides a valuable framework for hypothesis generation regarding plant metabolic networks and specialized compound biosynthesis.
• The platform aids in identifying genes controlling natural product biosynthesis, particularly in less-studied species.
• MPM is publicly available, supporting research in medicine and plant biology for drug discovery and development.